Brief: Centessa Pharmaceuticals Reports Q1 2023 Financial Results And Business Highlights

Centessa Pharmaceuticals

12/05/2023 14:36

May 12 (Reuters) - Centessa Pharmaceuticals Plc
 260Y.F :
    * CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS AND
BUSINESS
HIGHLIGHTS FOR THE FIRST QUARTER OF 2023
    * STRONG CLINICAL MOMENTUM AND CASH RUNWAY INTO 2026 TO
SUPPORT
MULTIPLE CLINICAL READOUTS ACROSS PIPELINE
    * CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF
$346.2
MILLION AS OF MARCH 31
    * QTRLY NET LOSS PER SHARE $0.53
    * Q1 EARNINGS PER SHARE VIEW $-0.41 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3S87Hz 
Further company coverage:  260Y.F 

 ((Reuters.Briefs@thomsonreuters.com;))